Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

4.

Neurotoxicity of MDMA and related compounds: anatomic studies.

Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA.

Ann N Y Acad Sci. 1990;600:649-61; discussion 661-4. Review.

PMID:
1979216
6.

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

Battaglia G, Yeh SY, De Souza EB.

Pharmacol Biochem Behav. 1988 Feb;29(2):269-74.

PMID:
2452449
7.
9.
11.
12.
14.
15.

Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine.

Scallet AC, Lipe GW, Ali SF, Holson RR, Frith CH, Slikker W Jr.

Neurotoxicology. 1988 Fall;9(3):529-37.

PMID:
2904668
17.

An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

Sprague JE, Everman SL, Nichols DE.

Neurotoxicology. 1998 Jun;19(3):427-41. Review.

PMID:
9621349
18.

(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.

Mokler DJ, Robinson SE, Rosecrans JA.

Eur J Pharmacol. 1987 Jun 19;138(2):265-8.

PMID:
2887440
19.

Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

Stone DM, Merchant KM, Hanson GR, Gibb JW.

Neuropharmacology. 1987 Dec;26(12):1677-83.

PMID:
2893986
20.
Items per page

Supplemental Content

Support Center